cagrilintide vs semaglutide CagriSema in Adults With or Without Diabetes – REDEFINE 1 & 2 • 💊 2.4 mg + 2.4 mg once weekly • 📉 –20.4% weight loss (non-diabetic) & –13.7% (T2D) Cagrilintide & GLP-1 S |

The post-treatment phase requires ongoing care to maintain results and manage potential side effects

If so, the receptors would continue to be resistant to the natural calming actions of GABA (See Chapter I), and the effect could be to prolong the state of nervous system hyperexcitability

This weekly schedule is consistent with other long-acting incretin-based therapies and is designed to maintain stable drug levels throughout the week

Diarrhea was reported in five subjects (7%) receiving VK2735 compared with four subjects (21%) receiving placebo

BRIEF DESCRIPTION OF THE DRAWINGS [0030] In order to more clearly illustrate the technical solutions in Examples of the present invention or in the prior art, the drawings to be used in the description of Examples or the prior art will be briefly described below

Psychoneuroendocrinology 38, 30853091